[ad_1]
Nísia Trindade Lima chairs the Oswaldo Cruz Foundation and highlights that the results of the various immunizers were published in various articles in scientific journals and were approved by Anvisa edit
247 – The president of the Oswaldo Cruz Foundation (Fiocruz), Nísia Trindade Lima, said, in an interview with the newspaper O Estado de S. Paulo, that she “would not suspect any vaccine”, commenting on the delay in making the information known. effectiveness of CoronaVac, Instituto Butantã and Chinese pharmaceutical Sinovac tests against Covid-19.
She, who chairs the laboratory linked to the Ministry of Health, was also enthusiastic about the National Immunization Plan prepared by the ministry, despite recognizing that the immunization of the Brazilian population against the new coronavirus should be extended until 2022.
Fiocruz expects to deliver 210.4 million doses of the vaccine against Covid-19 next year and has an agreement to produce an immunizer against the disease with the British laboratory AstraZeneca, in partnership with the University of Oxford.
Regarding suspicions about certain vaccines, Nísia points out that the results of the different immunizers had been published in several articles in scientific journals and were approved by the National Health Surveillance Agency (Anvisa).
“All the vaccines that are registered are safe, with different percentages of effectiveness, but certainly with the possibility of preventing diseases, deaths, which is a great concern,” he says.
Knowledge frees. know more
You who came so far Thank you very much for rating our content. Unlike the corporate media, Brasil 247 and TV 247 are financed through their own community of readers and viewers. It can support TV 247 and Brazil 247 website in various ways. See how at brasil247.com/apoio
